136 related articles for article (PubMed ID: 28802229)
1. TGF-β-mediated repression of MST1 by DNMT1 promotes glioma malignancy.
Guo Z; Li G; Bian E; Ma CC; Wan J; Zhao B
Biomed Pharmacother; 2017 Oct; 94():774-780. PubMed ID: 28802229
[TBL] [Abstract][Full Text] [Related]
2. Repression of Dok7 expression mediated by DNMT1 promotes glioma cells proliferation.
Hua CD; Bian EB; Chen EF; Yang ZH; Tang F; Wang HL; Zhao B
Biomed Pharmacother; 2018 Oct; 106():678-685. PubMed ID: 29990858
[TBL] [Abstract][Full Text] [Related]
3. TGF-β-induced miR10a/b expression promotes human glioma cell migration by targeting PTEN.
Liu S; Sun J; Lan Q
Mol Med Rep; 2013 Dec; 8(6):1741-6. PubMed ID: 24100613
[TBL] [Abstract][Full Text] [Related]
4. Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1.
Merzak A; McCrea S; Koocheckpour S; Pilkington GJ
Br J Cancer; 1994 Aug; 70(2):199-203. PubMed ID: 8054266
[TBL] [Abstract][Full Text] [Related]
5. LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway.
Tang F; Wang H; Chen E; Bian E; Xu Y; Ji X; Yang Z; Hua X; Zhang Y; Zhao B
J Cell Physiol; 2019 Dec; 234(12):23302-23314. PubMed ID: 31140621
[TBL] [Abstract][Full Text] [Related]
6. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.
Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC
Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373
[TBL] [Abstract][Full Text] [Related]
7. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.
Wick W; Grimmel C; Wild-Bode C; Platten M; Arpin M; Weller M
J Neurosci; 2001 May; 21(10):3360-8. PubMed ID: 11331365
[TBL] [Abstract][Full Text] [Related]
8. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a.
Ma CC; Xiong Z; Zhu GN; Wang C; Zong G; Wang HL; Bian EB; Zhao B
J Exp Clin Cancer Res; 2016 Jun; 35(1):90. PubMed ID: 27267902
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma.
Patel R; Shervington L; Lea R; Shervington A
Brain Res; 2008 Jan; 1188():173-81. PubMed ID: 18021753
[TBL] [Abstract][Full Text] [Related]
12. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
[TBL] [Abstract][Full Text] [Related]
13. Depletion of B cell CLL/Lymphoma 11B Gene Expression Represses Glioma Cell Growth.
Liao CK; Fang KM; Chai K; Wu CH; Ho CH; Yang CS; Tzeng SF
Mol Neurobiol; 2016 Aug; 53(6):3528-3539. PubMed ID: 26096706
[TBL] [Abstract][Full Text] [Related]
14. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
[TBL] [Abstract][Full Text] [Related]
15. N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.
Platten M; Wild-Bode C; Wick W; Leitlein J; Dichgans J; Weller M
Int J Cancer; 2001 Jul; 93(1):53-61. PubMed ID: 11391621
[TBL] [Abstract][Full Text] [Related]
16. TGF-β promotes glioma cell growth via activating Nodal expression through Smad and ERK1/2 pathways.
Sun J; Liu SZ; Lin Y; Cao XP; Liu JM
Biochem Biophys Res Commun; 2014 Jan; 443(3):1066-72. PubMed ID: 24370825
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
[TBL] [Abstract][Full Text] [Related]
18. Retinol dehydrogenase 10 promotes metastasis of glioma cells via the transforming growth factor-β/SMAD signaling pathway.
Guan F; Kang Z; Wang L; Wang K; Mao BB; Peng WC; Zhang BL; Lin ZY; Zhang JT; Hu ZQ
Chin Med J (Engl); 2019 Oct; 132(20):2430-2437. PubMed ID: 31613821
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of HTATIP2 expression is associated with promoter methylation and poor prognosis in glioma.
Dong X; Deng Q; Nie X; Zhang M; Jia W; Chen C; Xu C; Xu R
Exp Mol Pathol; 2015 Apr; 98(2):192-9. PubMed ID: 25617528
[TBL] [Abstract][Full Text] [Related]
20. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
